Search research articles
Contact Us
Filters
Showing results (31-40 of 174) with videos related to
Page
of 18
Sort By:
Rheumatology (Oxford, England)
|
December 15, 2010
Report on malignancies in the German juvenile idiopathic arthritis registry
Gerd Horneff, Ivan Foeldvari, Kirsten Minden, et al.
The Journal of Rheumatology
|
September 17, 2010
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort
Ivan Foeldvari, Svetlana I Nihtyanova, Angela Wierk, et al.
Ophthalmology
|
September 24, 2019
Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)
Uwe Pleyer, Kirsten Minden, Jens Klotsche, et al.
The Journal of Rheumatology
|
April 15, 2023
How Is Pulmonary Function Assessed in Patients With Juvenile Systemic Sclerosis? Do We Have a Good Clinical Standard?
Ivan Foeldvari, Bernd Hinrichs, Kathryn Torok, et al.
Journal of Clinical Pharmacology
|
August 3, 2004
Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis
Rubén Burgos-Vargas, Ivan Foeldvari, Angelika Thon, et al.
Seminars in Arthritis and Rheumatism
|
April 16, 2018
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach
Edoardo Marrani, Ivan Foeldvari, Jordi Anton Lopez, et al.
Microvascular Research
|
August 9, 2015
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
Francesca Ingegnoli, Patrizia Boracchi, Roberta Gualtierotti, et al.
RMD Open
|
April 14, 2017
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC
Anja Weiß, Kirsten Minden, Joachim Listing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 20, 2014
Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry
Heinrike Schmeling, Kirsten Minden, Ivan Foeldvari, et al.
Journal of Scleroderma and Related Disorders
|
November 18, 2024
Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement
Louise Sander, Ivan Foeldvari, Daniel Glaser, et al.
Page
of 18
Search research articles
Search
Showing results (31-40 of 174) with videos related to
Sort By:
Page
of 18
Rheumatology (Oxford, England)
|
December 15, 2010
Report on malignancies in the German juvenile idiopathic arthritis registry
Gerd Horneff, Ivan Foeldvari, Kirsten Minden, et al.
The Journal of Rheumatology
|
September 17, 2010
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort
Ivan Foeldvari, Svetlana I Nihtyanova, Angela Wierk, et al.
Ophthalmology
|
September 24, 2019
Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)
Uwe Pleyer, Kirsten Minden, Jens Klotsche, et al.
The Journal of Rheumatology
|
April 15, 2023
How Is Pulmonary Function Assessed in Patients With Juvenile Systemic Sclerosis? Do We Have a Good Clinical Standard?
Ivan Foeldvari, Bernd Hinrichs, Kathryn Torok, et al.
Journal of Clinical Pharmacology
|
August 3, 2004
Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis
Rubén Burgos-Vargas, Ivan Foeldvari, Angelika Thon, et al.
Seminars in Arthritis and Rheumatism
|
April 16, 2018
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach
Edoardo Marrani, Ivan Foeldvari, Jordi Anton Lopez, et al.
Microvascular Research
|
August 9, 2015
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study
Francesca Ingegnoli, Patrizia Boracchi, Roberta Gualtierotti, et al.
RMD Open
|
April 14, 2017
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC
Anja Weiß, Kirsten Minden, Joachim Listing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 20, 2014
Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry
Heinrike Schmeling, Kirsten Minden, Ivan Foeldvari, et al.
Journal of Scleroderma and Related Disorders
|
November 18, 2024
Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement
Louise Sander, Ivan Foeldvari, Daniel Glaser, et al.
Page
of 18